The interventional cardiology program at Yale New Haven Hospital is led by an expert team of physicians experienced in diagnosing and treating patients with structural heart disease, and complex and advanced coronary artery and peripheral vascular diseases.
Our interventional cardiologists perform more than 10,000 procedures a year on patients of all ages from around the world in advanced cardiac catheterization laboratories. They continually search for better minimally invasive methods for diagnosing and treating patients with narrowed blood vessels and complex valve disease.
These methods include innovative intracoronary and peripheral stent platforms, drug-coated balloons, and novel techniques and devices.The goals for the interventional team include providing comprehensive cardiac care to patients with complex and advanced atherosclerotic and valve disease, thereby improving patient outcomes. Further supporting our patient care is a robust research program that includes nationally recognized clinical trials.
Yale New Haven Hospital is among a select number of hospitals in the country, and the first hospital in Connecticut, to offer transcatheter aortic valve replacement (TAVR) as a treatment option for patients with severe aortic stenosis. The transcatheter procedure is easier on patients, typically offers a shorter recovery time than traditional surgery, and provides doctors with a new option to treat patients who are at increased risk for open-heart surgery. The hospital is certified as a Transcatheter Valve Center by the American College of Cardiology.
For patients with at-risk limbs, we offer a program aimed at preventing complications of peripheral arterial disease. This program uses novel medical techniques and innovative procedures.
Among the many procedures offered at YNHH are:
Our Comprehensive Coronary Physiology Program provides care for patients with chest pain that is chronic, unexplained or difficult to manage. Many patients experience chest pain due to coronary microvascular disease, coronary vasospasm, endothelial dysfunction, or myocardial bridging that may go undetected on routine evaluation such as stress testing. This program provides comprehensive evaluation to identify a patient’s underlying cause of symptoms. For more information, please call 203-785-4129.
At Yale New Haven Hospital, rapid time-to-treatment is a priority. Yale New Haven's median D2B time is 61 minutes, significantly shorter than the American Heart Association's recommended standard of 90 minutes.
With a heart attack, time is everything. In fact your chances of survival are dramatically increased if the blockage can be treated within 90 minutes of your arrival at the hospital. Known as the door-to-balloon time (D2B), it is a performance of the time between patient entrance in the emergency department and when angioplasty is performed.
At Yale New Haven, patients admitted with chest pain have a diagnostic EKG on average within six minutes of arrival and flow restored to the heart with angioplasty and stenting of the heart artery blockage within 61 minutes, when necessary. And our advancements with EMT professionals are helping to make these times even shorter.
